Molecular basis of inherited spastic paraplegias

Current Opinion in Genetics and Development

Volumn 11, Issue 3, 2001, Pages 336-342

  Casari, Giorgio ^a   Rugarli, Elena ^b  

^a Stem Cell Research Institute   (Italy)

^b TELETHON INSTITUTE OF GENETICS AND MEDICINE TIGEM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CHAPERONE; METALLOPROTEINASE; PARAPLEGIN; PROTEIN; SPASTIN; UNCLASSIFIED DRUG;

AUTOSOMAL DISORDER; CELL INTERACTION; GENE LOCATION; GENE MUTATION; GENETIC CODE; GENETIC DISORDER; GLIA CELL; HUMAN; MITOCHONDRION; MOLECULAR GENETICS; NERVE FIBER; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PYRAMIDAL TRACT; REVIEW; SPASTIC PARAPLEGIA;

EID: 0035370669     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(00)00199-4     Document Type: Review

References (66)

1. Harding A.E. Genetic aspects of autosomal dominant late onset cerebellar ataxia. J Med Genet. 18:1981;436-441.
2. Dürr A., Brice A., Serdaru M., Rancurel G., Derouesné C., Lyon-Caen O., Agid Y., Fontaine B. The phenotype of 'pure' autosomal dominant spastic paraplegia. Neurology. 44:1994;1274-1277.
3. Fink J.K. Advances in hereditary spastic paraplegia. Curr Opin Neurol. 10:1997;313-318.
4. Harding A.E. Classification of the hereditary ataxias and paraplegias. Lancet. 1:1983;1151-1154.
5. Harding A.E. Hereditary 'pure' spastic paraplegia. The Hereditary Ataxias and Related Disorders. 1984;174 Churchill Livingstone, New York.
6. Schwarz G.A., Liu C.N. Hereditary (familial) spastic paraplegia: further clinical and pathological observations. Arch Neurol Psychiatry. 75:1956;144-162.
7. Fink J.K., Heiman-Patterson T., Bird T., Cambi F., Dubé M.-P., Figlewicz D.A., Fink J.K., Haines J.L., Heiman-Patterson T., Hentati A., et al. Hereditary spastic paraplegia: advances in genetic research. Neurology. 46:1996;1507-1514.
8. Jouet M., Rosenthal A., Armstrong G., MacFarlane J., Stevenson R., Paterson J., Metzenberg A., Ionasescu V., Temple K., Kenwrick S. X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the LI gene. Nat Genet. 7:1994;402-407.
9. Fransen E., Vits L., Van Camp G., Willems P.J. The clinical spectrum of mutations in L1, a neuronal cell adhesion molecule. Am J Med Genet. 64:1996;73-77.
10. Schachner M. Cell surface recognition and neuron-glia interactions. Ann NY Acad Sci. 633:1991;105-112.
11. Joosten E.A., Gribnau A.A. Immunocytochemical localization of cell adhesion molecule L1 in developing rat pyramidal tract. Neurosci Lett. 100:1998;94-98.
12. Brummendorf T., Rathjen F.G. Structure/function relationships of axon-associated adhesion receptors of the immunoglobulin superfamily. Curr Opin Neurobiol. 6:1996;584-593.
13. Burden-Gulley S.M., Pendergast M., Lemmon V. The role of cell adhesion molecule L1 in axonal extension, growth cone motility and signal transduction. Cell Tissue Res. 290:1997;415-422.
14. Yamasaki M., Arita N., Hiraga S., Izumoto S., Morimoto K., Nakatani S., Fujitani K., Sato N., Hayakawa T. A clinical and neuroradiological study of X-linked hydrocephalus in Japan. J Neurosurg. 83:1995;50-55.
15. Dahme M., Bartsch U., Martini R., Anliker B., Schachner M., Mantei N. Disruption of the mouse L1 gene leads to malformations of the nervous system. Nat Genet. 17:1997;346-349.
16. Cohen N.R., Taylor J.S.H., Scott L.B., Guillery R.W., Soriano P., Furley A.J.W. Errors in corticospinal axon guidance in mice lacking the neural cell adhesion molecule L1. Curr Biol. 8:1997;26-33.
17. Demyanenko G.P., Tsai A.Y., Maness P.F. Abnormalities in neuronal process extension, hippocampal development, and the ventricular system of L1 knockout mice. J Neurosci. 19:1999;4907-4920.
18. Fransen E., D'Hogge R., Van Camp G., Verhoye M., Sijbers J., Reyniers E., Soriano P., Kamuguchi H., Willemsen R., Koekkoek S.K.E., et al. L1 knockout mice show dilated ventricles, vermis hypoplasia and impaired exploration patterns. Hum Mol Genet. 7:1998;999-1009.
19. Castellani V., Chedotal A., Schachner M., Faivre-Sarrailh C., Rougon G. Analysis of the L1-deficient mouse phenotype reveals cross-talk between Sema3A and L1 signaling pathways in axonal guidance. Neuron. 27:2000;237-249. This study provides the first functional explanation for the defects of the corticospinal tract observed in human patients with L1 mutations. By showing that L1 is a component of the Sema3A receptor complex, it suggests that L1 mutations may disrupt Sema3A signalling in the growth cones.
20. Saugier-Veber P., Munnich A., Bonneau D., Rozet J.M., Le Merrer M., Gil R., Boespflug-Tanguy O. X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus. Nat Genetics. 6:1994;257-262.
21. Yool D.A., Edgar J.M., Montague P., Malcolm S. The proteolipid protein gene and myelin disorders in man and animal models. Hum Mol Genet. 9:2000;987-992.
22. Woodward K., Malcolm S. Proteolipid protein gene. Paelizaeus-Merzbacher disease in humans and neurodegeneration in mice. Trends Genet. 15:1999;125-128.
23. Kobayashi H., Hoffman E.P., Marks H.G. The rumpshaker mutation in spastic paraplegia. Nat Genet. 7:1994;351-352.
24. Boison D., Stoffel W. Disruption of the compacted myelin sheets of axons of the central nervous system in proteolipid protein-deficient mice. Proc Natl Acad Sci USA. 91:1994;11709-11713.
25. Klugmann M., Schwab M.H., Pühlhofer A., Schneider A., Zimmermann F., Griffiths I.R., Nave K.-A. Assembly of CNS myelin in the absence of proteolipid protein. Neuron. 18:1997;59-70.
26. Griffiths I., Klugmann M., Anderson T., Yool D., Thomson C., Schwab M.H., Schneider A., Zimmermann F., McCulloch M., Nadon N., Nave K.A. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science. 280:1998;1610-1613.
27. De Michele G., De Fusco M., Cavalcanti F., Filla A., Marconi R., Volpe G., Monticelli A., Ballabio A., Casari G., Cocozza S. A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. Am J Hum Genet. 63:1998;135-139.
28. Casari G., De Fusco M., Ciarmatori S., Zeviani M., Mora M., Fernandez P., De Michele G., Filla A., Cocozza S., Marconi R., et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell. 93:1998;973-983.
29. Guélin E., Rep M., Grivell L.A. Afg3p, a mitochondrial ATP-dependent metalloprotease, is involved in degradation of mitochondrially encoded Cox1, Cox3, Cob, Su6, Su8 and Su9 subunits of the inner membrane complexes III, IV and V. FEBS Lett. 381:1996;42-46.
30. Pajic A., Tauer R., Feldmann H., Neupert W., Langer T. Yta10p is required for the ATP dependent degradation of polypeptides in the inner membrane of mitochondria. FEBS Lett. 353:1994;201-206.
31. Tzagoloff A., Yue J., Jang J., Paul M.F. A new member of a family of ATPases is essential for assembly of mitochondrial respiratory chain and ATP synthetase complexes in Saccharomyces cerevisiae. J Biol Chem. 269:1994;26144-26151.
32. Langer T. AAA proteases: cellular machines for degrading membrane proteins. Trends Biochem Sci. 25:2000;247-251.
33. Arlt H., Tauer R., Feldmann H., Neupert W., Langer T. The YTA10-12 complex, an AAA protease with chaperone-like activity in the inner membrane of mitochondria. Cell. 85:1996;875-885.
34. Leonhard K., Herrmann J.M., Stuart R.A., Mannhaupt G., Neupert W., Langer T. AAA proteases with catalytic sites on opposite membrane surfaces comprise a proteolytic system for the ATP-dependent degradation of inner membrane proteins in mitochondria. EMBO J. 15:1996;4218-4229.
35. Leonhard K., Stiegler A., Neupert W., Langer T. Chaperone-like activity of the AAA domain of the yeast Yme1 AAA protease. Nature. 398:1999;348-351.
36. Campbell C.L., Tanaka N., White K.H., Thorsness P.E. Mitochondrial morphological and functional defects in yeast caused by yme1 are suppressed by mutation of a 26S protease subunit homologue. Mol Biol Cell. 5:1994;899-905.
37. Hentati A., Pericak-Vance M.A., Lennon F., Wasserman B., Hentati F., Juneja T., Angrist M.H., Hung W.Y., Boustany R.M., Bohlega S. Linkage of a locus for autosomal dominant familial spastic paraplegia to chromosome 2p markers. Hum Mol Genet. 3:1994;1867-1871.
38. Hazan J., Fontaine B., Bruyn R.P.M., Lamy C., van Deutekom J.C.T., Rime C.-S., Dürr A., Melki J., Lyon-Caen O., Agid Y., et al. Linkage of a new locus for autosomal dominant familial spastic paraplegia to chromosome 2p. Hum Mol Genet. 3:1994;1569-1573.
39. Hazan J., Fonknechten N., Mavel D., Paternotte C., Samson D., Artiguenave F., Davoine C.S., Cruaud C., Durr A., Wincker P., et al. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet. 23:1999;296-303. Identification of the first autosomal dominant hereditary spastic paraplegia gene.
40. Beyer A. Sequence analysis of the AAA protein family. Protein Sci. 6:1997;2043-2058.
41. Hartman J.J., Marh J., McNally K., Okawa K., Iwamatsu A., Thomas S., Cheesman S., Heuser J., Vale R.D., McNally F.J. Katanin, a microtubule-severing protein, is a novel AAA ATPase that targets to the centrosome using a WD40-containing subunit. Cell. 93:1998;277-287.
42. Hartman J.J., Vale R.D. Microtubule disassembly by ATP-dependent oligomerization of the AAA enzyme katanin. Science. 286:1999;782-785.
43. Bishop N., Woodman P. ATPase-defective mammalian VPS4 localizes to aberrant endosomes and impairs cholesterol trafficking. Mol Biol Cell. 11:2000;227-239.
44. Yoshimori T., Yamagata F., Yamamoto A., Mizushima N., Kabeya Y., Nara A., Miwako I., Ohashi M., Ohsumi M., Ohsumi Y. The mouse SKD1, a homologue of yeast Vps4p, is required for normal endosomal trafficking and morphology in mammalian cells. Mol Biol Cell. 11:2000;747-763.
45. Schnall R., Mannhaupt G., Stucka R., Tauer R., Ehnle S., Schwarzlose C., Vetter I., Feldmann H. Identification of a set of yeast genes coding for a novel family of putative ATPases with high similarity to constituents of the 26S protease complex. Yeast. 10:1994;1141-1155.
46. Liberzon A., Shpungin S., Bangio H., Yona E., Katcoff D.J. Association of yeast SAP1, a novel member of the 'AAA' ATPase family of proteins, with the chromatin protein SIN1. FEBS Lett. 10:1996;5-10.
47. Cox G.A., Mahaffey C.L., Nystuen A., Letts V.A., Frankel W.N. The mouse fidgetin gene defines a new role for AAA family proteins in mammalian development. Nat Genet. 26:2000;198-202.
48. Azim AC, Hentati A, U HMF, Hirano M, Ouachi K, Siddique T: Spastin, a new AAA protein, binds to α and β tubulins [Abstract]. Am J Hum Genet 2000, 67(Suppl 2):1056.
49. Hedera P., DiMauro S., Bonilla E., Wald J.J., Fink J.K. Mitochondrial analysis in autosomal dominant hereditary spastic paraplegia. Neurology. 55:2000;1591-1592.
50. Fonknechten N., Mavel D., Byrne P., Davoine C.-S., Cruaud C., Boentsch D., Samson D., Coutinho P., Hutchinson M., McMonagle P., et al. Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet. 9:2000;63-6447.
51. Lindsey J.C., Lusher M.E., McDermott C.J., White K.D., Reid E., Rubinsztein D.C., Bashir R., Hazan J., Shaw P.J., Bushby K.M.D. Mutation analysis of the spastin gene (SPG4) in patients with hereditary spastic paraparesis. J Med Genet. 37:2000;759-765.
52. Santorelli F.M., Patrono C., Fortini D., Tessa A., Comanducci G., Bertini E., Pierallini A., Amabile G.A., Casali C. Intrafamilial variability in hereditary spastic paraplegia associated with an SPG4 gene mutation. Neurology. 55:2000;702-705.
53. White K.D., Ince P.G., Lusher M., Lindsey J., Cookson M., Bashir R., Shaw P.J., Bushby K.M.D. Clinical and pathologic findings in hereditary spastic paraparesis with spastin mutation. Neurology. 55:2000;89-94.
54. Hentati A., Deng H.-X., Zhai H., Chen W., Yang Y., Hung W.-Y., Azim A.C., Bohlega S., Tandan R., Warner C., et al. Novel mutations in spastin gene and absence of correlation with age at onset of symptoms. Neurology. 55:2000;1388-1390.
55. Burger J., Fonknechten N., Hoeltzenbein M., Neumann L., Bratanoff E., Hazan J., Reis A. Hereditary spastic paraplegia caused by mutations in the SPG4 gene. Eur J Hum Genet. 8:2000;771-776.
56. Hazan J., Lamy C., Melki J., Munnich A., de Recondo J., Weissenbach J. Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q. Nat Genet. 5:1993;163-167.
57. Hentati A., Pericak-Vance M.A., Hung W.Y., Belal S., Laing N., Boustany R.M., Hentati F., Ben Hamida M., Siddique T. Linkage of 'pure' autosomal recessive familial spastic paraplegia to chromosome 8 markers and evidence of genetic locus heterogeneity. Hum Mol Genet. 3:1994;1263-1267.
58. Fink J.K., Wu C.T., Jones S.M., Sharp G.B., Lange B.M., Lesicki A., Reinglass T., Varvil T., Otterud B., Leppert M. Autosomal dominant familial spastic paraplegia: tight linkage to chromosome 15q. Am J Hum Genet. 56:1995;188-192.
59. Reid E., Dearlove A.M., Whiteford M.L., Rhodes M., Rubinsztein D.C. Autosomal dominant spastic paraplegia: refined SPG8 locus and additional genetic heterogeneity. Neurology. 53:1999;1844-1849.
60. Lo Nigro C., Cusano R., Scaranari M., Cinti R., Forabosco P., Morra V.B., De Michele G., Santoro L., Davies S., Hurst J., et al. A refined physical and transcriptional map of the SPG9 locus on 10q23.3-q24.2. Eur J Hum Genet. 8:2000;777-782.
61. Reid E., Dearlove A.M., Rhodes M., Rubinsztein D.C. A new locus for autosomal dominant 'pure' hereditary spastic paraplegia mapping to chromosome 12q13, and evidence for further genetic heterogeneity. Am J Hum Genet. 65:1999;757-763.
62. Martinez Murillo F., Kobayashi H., Pegoraro E., Galluzzi G., Creel G., Mariani C., Farina E., Ricci E., Alfonso G., Pauli R.M., Hoffman E.P. Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15. Neurology. 13:1999;50-56.
63. Reid E., Dearlove A.M., Osborn O., Rogers M.T., Rubinsztein D.C. A locus for autosomal dominant 'pure' hereditary spastic paraplegia maps to chromosome 19q13. Am J Hum Genet. 66:2000;728-732.
64. Fontaine B., Davoine C.S., Durr A., Paternotte C., Feki I., Weissenbach J., Hazan J., Brice A. A new locus for autosomal dominant pure spastic paraplegia, on chromosome 2q24-q34. Am J Hum Genet. 66:2000;702-707.
65. Vazza G., Zortea M., Boaretto F., Micaglio G.F., Sartori V., Mostacciuolo M.L. A new locus for autosomal recessive spastic paraplegia associated with mental retardation and distal motor neuropathy, SPG14, maps to chromosome 3q27-q28. Am J Hum Genet. 67:2000;504-509.
66. Tamagaki A., Shima M., Tomita R., Okumura M., Shibata M., Morichika S., Kurahashi H., Giddings J.C., Yoshioka A., Yokobayashi Y. Segregation of a pure form of spastic paraplegia and NOR insertion into Xq11.2. Am J Med Genet. 94:2000;5-8.